Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto in Heart Failure Reverse Remodeling
NCT02754518Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Apr 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sacubitril + valsartan in heart failure (HF), sponsored by University of Chicago. Primary endpoint: LV Remodeling 2D End-Diastolic Diameter at 1 year. Started Apr 2016; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02754518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02754518.